tibolone and norgestrel
tibolone has been researched along with norgestrel in 4 studies
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Cooke, TM; Harrison, RF; Kelly, A; McGill, T; Milner, MH; Sinnott, MM | 1 |
Barnes, JF; Calder, A; Ekevall, K; Farish, E; Fletcher, CD; Hart, DM | 1 |
Alder, EM; Brown, J; Cawood, EH; Gebbie, AE; Ross, LA | 1 |
Boerstoel-Streefland, M; Hendricks, PT; Wierik, EJ | 1 |
Trials
3 trial(s) available for tibolone and norgestrel
Article | Year |
---|---|
A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Lipoproteins; Mice; Middle Aged; Norgestrel; Norpregnenes; Triglycerides | 1996 |
Effects of tibolone on serum lipoprotein and apolipoprotein levels compared with a cyclical estrogen/progestogen regimen.
Topics: Anabolic Agents; Apolipoproteins; Cardiovascular Diseases; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Middle Aged; Norgestrel; Norpregnenes; Postmenopause; Progesterone Congeners; Treatment Outcome | 1999 |
Psychological effects of hormone replacement therapy: a comparison of tibolone and a sequential estrogen therapy.
Topics: Aged; Anabolic Agents; Anxiety; Depression; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Linear Models; Middle Aged; Norgestrel; Norpregnenes; Premenopause; Progesterone Congeners; Prospective Studies | 1999 |
Other Studies
1 other study(ies) available for tibolone and norgestrel
Article | Year |
---|---|
Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus study.
Topics: Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Endometrial Neoplasms; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norgestrel; Norpregnenes; Practice Patterns, Physicians'; Registries; Retrospective Studies; Risk Factors; United Kingdom | 2004 |